DFX Intelligence

Data Factory

P•••••• T•••••••••: company on the venture capital graph | DFX Data Factory

The names on this page are hidden. Create a free account to reveal 5 records a month, or get Venture Capital Intelligence at $199 a month for every name. Every figure, date and source on this page is public either way.

VentureCompany

P•••••• T•••••••••

Muscle loss is a major challenge associated with a range of conditions, including GLP-1–based weight-loss drugs and aging (sarcopenia). Current discovery app

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:0cd14b68-6932-46f2-8465-e7ee8ec992a0

Data as of Sep 17, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 22, 2026, 10:37 AM UTC and rebuilt at most every 15 minutes.

Relationships: 1
Dated events: 0
On other graphs: 1
Observed: Sep 14, 2026 to Sep 17, 2026
5 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

P•••••• T•••••••••

Portfolio company · cited

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Rounds: 0
Investors: 1
People: 0
Website: profuse-tech.com

Investors

Investor	Class	Fund	Partner	Role	Attribution
S••••• C••••••• L••	PE with venture activity	n/a	n/a	unknown	Unknown

Relationships

Invested in (1)

← S••••• C••••••• L••FirmPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site

Dated events

No dated event names this entity yet.

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:0cd14b68-6932-46f2-8465-e7ee8ec992a0
First observed: Sep 14, 2026
Last observed: Sep 17, 2026 5 days ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.